John M. Kirkwood,
Michael T. Lotze,
Joyce M. Yasko
Current Medicine Group
4e druk, 2001
9781573401760
Current Cancer Therapeutics
Specificaties
Paperback, 490 blz.
|
Engels
Current Medicine Group |
4e druk, 2001
ISBN13: 9781573401760
Rubricering
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
The updated Fourth Edition of Current Cancer Therapeutics offers contributions by by more than 60 renowned authors. The book provides an insightful guide to the overwhelming influx of new information and knowledge on an array of cancer types, as well as protocols for treatment and supportive care. Cutting-edge information, along with with a variety of professionally prepared tables and charts, makes this an unparalleled resource for all healthcare professionals.
Specificaties
ISBN13:9781573401760
Taal:Engels
Bindwijze:paperback
Aantal pagina's:490
Uitgever:Current Medicine Group
Druk:4
Inhoudsopgave
1: Agents.- 1. Alkylating and Platinating Agents.- 2. Antimetabolic Agents.- 3. Biologic Agents.- 4. Hormonal Agents.- 5. Tubulin-Targeting Drugs.- 2: Specific Neoplasms and Therapeutic Protocols.- 6. Breast Cancer.- 7. Upper Gastrointestinal Cancer.- 8. Lower Gastrointestinal Cancer.- 9. Head and Neck Cancer.- 10. Lung Cancer.- 11. Melanoma and Other Tumors of the Skin.- 12. Sarcomas.- 13. Genitourinary Cancer.- 14. Gynecologic Malignancies.- 15. Malignant Glioma.- 16. Endocrine Cancer.- 17. Leukemia.- 18. Hodgkin’s Disease.- 19. Non-Hodgkin’s Lymphoma.- 20. Myeloma.- 21. Malignant Effusions in the Chest.- 22. Carcinoma of Unknown Primary.- 23. Aids-Related Malignancies.- 3: Supportive Care.- 24. Palliative Care.- 25. Myelosuppression.- 26. Gastrointestinal Toxicities.- 27. Renal and Metabolic Complications.- 28. Pulmonary and Cardiovascular Complications of Cancer Therapy.- 29. Neurotoxicities.- 30. Evaluation of Quality of Life in Cancer Clinical Trials.- 31. Systemic Manifestations of Cancer and Management of Systemic Paraneoplastic Syndromes.- 32. Malnutrition.- 4: Clinical Trial Data Collection.- 33. Clinical Trials: Monitoring and Reporting of Toxicities, and Evaluating Tumor Response.- 34. Synoptic Pathology Reports.
